Technology | 2015.08.31
Regis Shares Expert Advice on Impurities in Drug Development
Impurities impact not only the safety of drugs, but also the drug development time, if not addressed early during the scale-up process. Regis Technologies, Inc. , a Chicago-based CMO, shares a collection advice from recent seminars to characterize impurities and expedite small molecule drugs safely to market.
(PRWeb August 31, 2015)
Read the full story at http://www.prweb.com/releases/drugdevelopment/impurities/prweb12930718.htm
For more information, please visit
http://www.prweb.com/releases/drugdevelopment/impurities/prweb12930718.htm
